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STATUS OF SMEAR POSITIVE PULMONARY TUBERCULOSIS PATIENTS
AFTER CHEMOTHERAPY UNDER THE DISTRICT TUBERCULOSIS
PROGRAMME*
Manjula Datta
Summary : In North Arcot district, where Short
Course Chemotherapy (SCC) had been
introduced in 1983, a cross sectional survey was
carried out in respect of smear positive
patients put on SCC or traditional regimens
between April 1986 and March 1988. It was
found that 19% of the treatment cards from the
D . T . C .  w e r e  i n  r e s p e c t  o f  d u p l i c a t e
registrations. The address  g iven was
inadequate in 13% of the cards. Only 69% of
the smear positive patients had accepted short
course chemotherapy and the rest were given
traditional regimens. The cross sectional
survey covered the period 6 to 36 months after
the start of treatment. Overall mortality in
patients with tuberculosis was 28% during 36
months. It was 3-5 times as high in those who
had taken less than 50% of chemotherapy,
irrespective of age. Thirty one percent of the
patients were smear positive at the time of the
home visit. However, among those who had
taken 80% or more of chemotherapy, 20% on
SCC and 26% placed on conventional treat-
ment were sputum positive. Nonetheless, even
among those who had taken less than 50% of
chemotherapy about 58% were sputum
negative.
Introduction
Short Course Chemotherapy (SCC) regimens
have been introduced in the National
Tuberculosis Programme since 1983. The first
district to benefit was North Arcot in Tamil
Nadu. A fully intermittent twice weekly
supervised regimen with Rifampicin 450 mg, INH
600 mg and Pyrazinamide 2 gms for the first two
months followed by Rifampicin 450 mg and INH
600 mg for the next four months is in operation
there. It was expected that introducing regimens
of short duration will increase treatment
compliance and, thus, contribute to improving the
tuberculosis situation in the district.
The routine monthly returns from the district,
however, have shown that the compliance to
chemotherapy has only improved from about 25-
30% with the traditional regimens to about 45%
with the short course regimen.B sides,
information on the bacteriological response to
treatment or relapse among these patients is not
available. Attempts at collecting the ‘end of
chemotherapy’and subsequent sputum
specimens in these patients had been successful
in only a small number of patients. Even this
small success was not achieved in patients who
got “lost” or those who did not complete
chemotherapy. In order to evaluate the result of
SCC under district programme conditions, it is
essential to collect this information.
The study was undertaken to assess both the
clinical and bacteriological status of patients u-ho
were started on SCC or traditional anti-TB
chemotherapy for smear positive pulmonary
tuberculosis during a specified period (i.e. April
1986-March 1988) in the North Arcot district.
Objectives
1. To study the fate of smear positive
patients started on anti-tuberculosis chemo-
therapy in a district.
2. To relate the fate to the amount of
chemotherapy consumed, as well as to the status
of case-holding i.e.those who discontinued
treatment or got lost and those who remained
under treatment till the end of treatment period
Methods
The study was a one point cross sectional
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survey and not a cohort analysis. Treatment cards
of all the patientswith smearpositive
tuberculosis, i.e. ‘B’ cases, were obtained from
the District Tuberculosis Centre, Vellore. These
cards were sorted Taluk-wise. The Peripheral
Health Institutions in the district were then
visited. The cards on hand were checked with
those in the PHI records, and any omissions were
added to our list.
Information regarding drug regimen, date of
start of treatment, amount of drugs collected and
place of residence was obtained from the
collected treatment cards. The patients were then
contacted in their homes and two specimens of
sputum were collected (one spot specimen and
one overnight specimen). At the time of the
house visit, information on symptom status and
subsequent chemotherapy, if any, was also
collected. Sputum specimens were transported to
the laboratory where they were examined for
smear and culture for AFB. All positive cultures
were tested for sensitivity to Streptomycin, INH
and Rifampicin.
House visits were carried out between
November 1988 and July 1989. Thus, the period
after the start of treatment, when the patients
were contacted in their homes ranged from 6 to
36 months.
 Results
1. Study Population
There were 4,233 treatment cards, registered
between 1.4.86 and 31.3.88. Cross indexing and
identification done during house visits showed
that several patients had more than one card,
  some as many asfive. There were 799 such
duplicate cards and seventy seven cards of out-of-
the-district cases. This left 3,357 newly registered
pat ents from North Arcot district for study and
analysis. Of these, 2,305 had been given SCC and
1052 one of the four traditional regimens, giving
an acceptance rate of 60% for SCC regimens.
Chart 1 gives the census status of these
pati nts, during the house visits, and the coverage
for sputum collection. It is seen that addresses
were inadequate in 14%; 10% had migrated and
could not be traced and 22% had died. The
 remaining1,830 (54%) patients could be
contacted in their homes and sputum could be
collected from 1,785 (97%). In this manner, the
status of 2,512 (75%) out 3,357 patients could be
known. These coverages are high and, thus, this
paper represents the status of all the patients in
the district. Table 2 shows the census status of the
2,305 patients on SCC and 1,052 on traditional
regimens separately according to the time of
contact in months after the start of treatment.
Out of 2,305 patients who were started on
short course regimens, 43% had completed 80%
or more of treatment. Forty one percent
completed it within thestipulated period of 8
months allowed to complete the treatment. Forty
thre  percent had taken less than 50% of
4233 Cards
Duplicate Out of Dist. No. Eligible
799 77 3357
SCC Non-SCC
2305 1052
I
Contacted Dead      Left Not Avail.   ContactedDead Left Not Avail.
1313 443 245 304 517 162
(57%) (19%) (11%) (13%) (49%) (15%)
I I
Sp. Collected Sp. Collected
1291 494
(98%) (95%)
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Table 2. Distribution of patients according to time of contact from start of treatment
Time of contact (Months) No. eligible No. dead No. available No. not available
Short course regimen
< 9 298 38 189 71
9-11 235 34 143 58
12-17  615 110 368 137
18-23 580 135 295 150
24+ 577 126 318 133
Total 2305 443 1313 549
(100%) (19%) (57%) (24%)
< 9 46
9-11 132
12-17 232
18-23 239
24+ 403
Traditional regimen
8 28 10
29 75 28
57 115 60
75 124 40
115 175 113
Total 1052 284 517
(100%) (27%) (49%)
Table 3. Duration of treatment related to drug consumption /collection
251
(24%)
Regimen
SCC
(52 Doses)
Duration of Number of patients according to percentage drugs consumed
treatment
(months) < 50 50-79 > 80 Total     
2 642 642
2-3 266 65 331
4-5 64 146 164 374
6-8 14 89 789 892
9+ 7 16 43 66
Total 993 316 996 2305
(43%) (13%) (43%) (100%)
Traditional
(12Collections) 3 442 2 444
3-4 70 4 74
5-8 22 98 4 124
9-11 35 41 76
12-14 1 7 94 102
15-17 113 113
18+ 1 4 114 119
Total 536 150 366 1052
(51%) (14%) (35%) (100%)
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treatment. Of the 1052 patients on traditional
chemotherapy, 35% had taken 80% or more of
chemotherapy. However, 21 % had taken longer
than the specified period of 15 months allowed
for the purpose. Fifty one percent took less than
50% of treatment (Table 3).
No comparisons are made in this presentation
between short course and traditional regimens as
we are primarily interested in the status of all the
patients in the district taken together for anti-
tubercular treatment under programme
conditions.
The overall mortality was 28% (Table 4). The
mortality in those who had taken less than 50% of
chcmothcrapy was 3-5 times higher than in those
who had taken 80% or more of chemotherapy,
and this is seen in all age groups.
4. Bacteriological Status
Thirty one percent of all patients who had
been started on anti-tuberculosis chemotherapy
were found to be bacteriologically positive at the
time of our visit, which ranged between 6 months
to 36 months after the start of treatment (Table
5). Of those who had completed 80% of
treatment, 22% were positive, and of those who
had taken only 50% or less, 42% were positive. It
is to be noted that even among those who had
taken only 50% or less treatment, 58% were
found to be negative. There was not much
difference between SCC regimen and the
traditional regimens.
5. Resistance to Anti-TB Drugs
Out of 1,783 patients in whom culture results
were available, 560 (31%) were found to be
positive. Of these,145 (20%) were resistant to
Streptomycin; 365 (65%) were resistant to INH
Number of patients by percentage of drugs consumed
Age group Sex < 50% 50-79% > 80% Total
(years) No. No. No. No. No. No. No. No.
Exam. Dead Exam. Dead Exam. Dead Exam. Dead
upto 15 M 2 2 3 7 -
F 5 2 - 7 I 12 3
B 7 2 2 10 1 19 3
15-24 M 69 23 30 5 100 S 199 33
F 53 19 16 2 65 5 134 26
B 122 42(34) 46 7(15) 165 10 (6) 333 59 (18)
25-44 M 360 159 117 21 337 28 814 208
F 127 55 41 13 168 10 336 78
B 487 214(44) 158 34 (22)505 38(8) 1150 286 (25)
45-64 M 408 228 112 32 308 39 828 299
F 50 24 15 6 59 6 124 36
B 458 252(55) 127 38(30) 367 45 (12) 952 335 (35)
65+ M 39 25 13 7 46 10 98 42
F 2 2 1 2 5 2
B 41 27 (66) 14 7 (-) 48 10 (21) 103 44 (33)
Total M 878 435 274 65 704 82 1946 582
F 237 102 73 21 301 22 611 145
B 1115 537(48) 347 86 (25)1095 104 (10)2557 727(28)
Figures within brackets are percentages
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Table 5. Bacteriological status according to the amount of drugs consumed and time of contact after start of treatment
Time of contact Number of patients by percentage of drugs consumed
< 50 (50-79) > 80 Total
(months) No. Exam. No. Pos. No. Exam. No. Pos. No. Exam.No. Pos. No. Exam. No. Pos.
SCC Regimen
upto9 74 37 31 13 84 22 189 72
9-14 119 45 52 17 154 25 325 87
15-17 75 32 34 15 73 13 182 60
18-23 93 41 46 17 151 30 290 88
24+ 99 42 45 10 159 33 303 85
Total 460 197 208 72 621 123 1289 392
(42%) (35%) (20%)         (30%)
Traditional Regimen
up to12 32 12 14 7 47 8 93 34
12-14 26 13 5 1 32 5 63 19
15-17 15 4 4 1 29 6 48 11
18-23 48 17 17 9 53 21 118 47
24+ 75 29 7 2 90 26 172 57
Total 196 82 47 30 251 66 494 168
(42% ) (43%) (26%) (34%)
Both 656 279 255 92 872 189 1783 560
(42%) (36%) (22%) (31%)
Table 6. Drug resistance status according to the amount of drugs consumed under SCC and traditional regimens
 P e r c e n t
 drug consumed
Resistant to
S H R
No. examined No. % No. % No. %
  
SCC Regimen
> 80 66 32 48 59 89 7 11
Total 168 63 38 124 74 20 12
Both 560 145 26 365 65 67 12
and 67 (12%)were resistant to Rifampicin (Tablehad not received short course treatment. This
6). probably means that patients either concealed
INH resistance was significantly higher inhistory of previoustreatment or that they
those who had been put on traditional regimens.received Rifampicin outside the programme,
Rifampicin resistance was seen even in those whowithout being aware of it.
